Sponsor Pipeline

Flare Therapeutics Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT05929235
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced…		 Enrollment closed, study ongoing
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-22 NCT07719361 A Study in Patients With Metastatic Castration-Resistant Prostate Cancer Phase 1 Recruiting
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07719361 A Study in Patients With Metastatic Castration-Resistant Prostate Cancer Metastatic Castration Resistant Prostate Cancer Recruiting
NCT05929235 A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced… Advanced Urothelial Carcinoma Active, Not Recruiting
Disease Areas
Bladder Cancer (1) Prostate Cancer (1)
Get alerts when Flare Therapeutics Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free